Lantheus Holdings (LNTH) Stock Price, Quote & News

Company Profile

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area wi...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 978 671 8001

Fax: 978 671 8860

Website: www.lantheus.com

Address:

201 Burlington Road, South Building, Bedford, United States

ChromeOnTheWheels Aug. 22 at 9:53 PM

$ZETA You’d be crazy not to swing trade in this volatile market. But some stocks I always keep a core position in due to the enormous upside $TALK $LNTH

1 · Reply

DKFutureInvest Aug. 22 at 5:28 PM

$LNTH Pretty sure $60 got shorted

0 · Reply

Longterminvestor919 Aug. 22 at 5:14 PM

$LNTH a lot of sell orders set at $60

0 · Reply

RadioIsotope25 Aug. 22 at 2:37 AM

$RADX Biotech’s with LU-177 drugs that were acquired. Radiopharm has a pipeline flush of them and ceo is ex- Novartis. $MNPR $LNTH $CLRB

1 · Reply

Longterminvestor919 Aug. 21 at 6:19 PM

$LNTH one thing I look at is Telix. LNTH has twice the revenue as Telix yet both companies currently have the same market cap. Either LNTH is severely undervalued or TLX is severely overvalued

1 · Reply

Longterminvestor919 Aug. 21 at 5:58 PM

$LNTH my guess is that the company has been very busy buying back shares. Any day now we should get news of MK-6240 NDA being filed with the FDA. I see $70 on deck

0 · Reply

DKFutureInvest Aug. 21 at 5:10 PM

$LNTH Think the price will just continue to go up? Seems planned.

2 · Reply

outlawinvestor1 Aug. 21 at 3:32 PM

$RADX nice table of historical comps in radiopharm. we’re super early here! $NVS $BMY $LNTH $CATX

1 · Reply

Live2ride Aug. 21 at 2:43 PM

$LNTH Ok, we are into that gap area between 57 and 73. Hopefully most sellers are gone and we can move back to the 60's soon. It's a start.

0 · Reply

Blizzzard Aug. 21 at 2:32 PM

$LNTH this shit is so bullish

0 · Reply

Lantheus Holdings, Inc. (LNTH) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 10:09 AM EDT - 17 days ago

Lantheus Holdings: Reassessing The Buy Thesis

Aug 6, 2025, 6:45 AM EDT - 17 days ago

Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent

Jul 22, 2025, 7:00 AM EDT - 4 weeks ago

Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D

Jul 21, 2025, 8:57 AM EDT - 4 weeks ago

Lantheus Holdings: Forget The Short Term Noise

Jul 16, 2025, 2:45 PM EDT - 5 weeks ago

Why Is Lantheus Stock Trading Lower On Wednesday?

Jul 1, 2025, 7:28 AM EDT - 7 weeks ago

Lantheus Seems Worth The (Very Real) Risks

Jun 11, 2025, 4:01 PM EDT - 2 months ago

Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

Jun 10, 2025, 8:30 AM EDT - 2 months ago

Lantheus to Present at the 2025 Truist Securities MedTech Conference

Jun 2, 2025, 8:00 AM EDT - 2 months ago

PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer

GEHC

May 14, 2025, 3:26 PM EDT - 3 months ago

Lantheus Holdings: Poor Results Caused By Temporary Problems - A Buy

May 8, 2025, 6:50 PM EDT - 3 months ago

Lantheus Holdings, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH

May 7, 2025, 11:23 AM EDT - 3 months ago

Lantheus Holdings, Inc. (LNTH) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:01 PM EDT - 3 months ago

Lantheus Announces Sale of SPECT Business to SHINE Technologies

Apr 30, 2025, 8:30 AM EDT - 4 months ago

Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

Apr 23, 2025, 8:30 AM EDT - 4 months ago

Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time

Apr 1, 2025, 9:00 AM EDT - 5 months ago

Lantheus Completes Acquisition of Evergreen Theragnostics

Mar 7, 2025, 11:12 AM EST - 6 months ago

Lantheus Holdings: Pylarify Makes Bull Case Despite Looming Patent Expiry

Feb 26, 2025, 10:49 AM EST - 6 months ago

Lantheus Holdings, Inc. (LNTH) Q4 2024 Earnings Call Transcript

Jan 30, 2025, 8:30 AM EST - 7 months ago

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D.

Jan 28, 2025, 6:30 AM EST - 7 months ago

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader

Jan 13, 2025, 12:05 AM EST - 7 months ago

Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer's Disease Radiodiagnostic Market

Jan 1, 2025, 7:43 PM EST - 8 months ago

Lantheus Holdings: Powerhouse Potential In 2025

Dec 12, 2024, 2:01 PM EST - 9 months ago

Lantheus Holdings: A Growing Business With Dominant Market Share

Nov 20, 2024, 1:00 AM EST - 9 months ago

Lantheus Announces Share Repurchase Program

Nov 13, 2024, 8:30 AM EST - 10 months ago

Lantheus to Present at the Jefferies London Healthcare Conference

Nov 11, 2024, 7:39 AM EST - 10 months ago

Lantheus Continues to Commend CMS' CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY's Blockbuster Status for 2025

Nov 8, 2024, 10:06 AM EST - 10 months ago

Lantheus Holdings: Q3 Results Were Good But Market Overreacted

Nov 6, 2024, 11:27 AM EST - 10 months ago

Lantheus Holdings, Inc. (LNTH) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 7:30 AM EST - 10 months ago

Lantheus Applauds CMS' CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care

Oct 23, 2024, 8:30 AM EDT - 10 months ago

Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time

Sep 15, 2024, 8:45 AM EDT - 1 year ago

Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024

Sep 5, 2024, 8:30 AM EDT - 1 year ago

Lantheus Appoints Julie Eastland as New Board Member

Aug 28, 2024, 8:30 AM EDT - 1 year ago

Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 12, 2024, 3:32 PM EDT - 1 year ago

Lantheus: A Radiopharmaceutical Powerhouse In The Making (Q2 2024 Update)

Aug 12, 2024, 7:15 AM EDT - 1 year ago

13 stocks to consider if you're able to brave recession fears

CWAN ESNT FUL ISRG KO MA MKTX

Jul 31, 2024, 12:18 PM EDT - 1 year ago

Lantheus Holdings, Inc. (LNTH) Q2 2024 Earnings Call Transcript

ChromeOnTheWheels Aug. 22 at 9:53 PM

$ZETA You’d be crazy not to swing trade in this volatile market. But some stocks I always keep a core position in due to the enormous upside $TALK $LNTH

1 · Reply

DKFutureInvest Aug. 22 at 5:28 PM

$LNTH Pretty sure $60 got shorted

0 · Reply

Longterminvestor919 Aug. 22 at 5:14 PM

$LNTH a lot of sell orders set at $60

0 · Reply

RadioIsotope25 Aug. 22 at 2:37 AM

$RADX Biotech’s with LU-177 drugs that were acquired. Radiopharm has a pipeline flush of them and ceo is ex- Novartis. $MNPR $LNTH $CLRB

1 · Reply

Longterminvestor919 Aug. 21 at 6:19 PM

$LNTH one thing I look at is Telix. LNTH has twice the revenue as Telix yet both companies currently have the same market cap. Either LNTH is severely undervalued or TLX is severely overvalued

1 · Reply

Longterminvestor919 Aug. 21 at 5:58 PM

$LNTH my guess is that the company has been very busy buying back shares. Any day now we should get news of MK-6240 NDA being filed with the FDA. I see $70 on deck

0 · Reply

DKFutureInvest Aug. 21 at 5:10 PM

$LNTH Think the price will just continue to go up? Seems planned.

2 · Reply

outlawinvestor1 Aug. 21 at 3:32 PM

$RADX nice table of historical comps in radiopharm. we’re super early here! $NVS $BMY $LNTH $CATX

1 · Reply

Live2ride Aug. 21 at 2:43 PM

$LNTH Ok, we are into that gap area between 57 and 73. Hopefully most sellers are gone and we can move back to the 60's soon. It's a start.

0 · Reply

Blizzzard Aug. 21 at 2:32 PM

$LNTH this shit is so bullish

0 · Reply

RobotMumba100 Aug. 21 at 2:30 PM

$MOH adding this gem... togheter with pharma $UNH and $LNTH

0 · Reply

RobotMumba100 Aug. 21 at 12:29 PM

$LNTH yes downgrade, but target is 99$.... soon we will come back 3 digits...

1 · Reply

DKFutureInvest Aug. 21 at 10:54 AM

$LNTH Another downgrade, let’s see if it crushes bullish momentum.

0 · Reply

Live2ride Aug. 20 at 9:41 PM

$LNTH I'm showing 3.3million shares traded after hours. Wow!

1 · Reply

TI7812 Aug. 20 at 6:40 PM

$LNTH will it make into the huge downside gap. Maybe if Jackson Hole doesn't tank the market, it could by this Friday.

1 · Reply

ChromeOnTheWheels Aug. 19 at 12:48 AM

$CPRX $REGN $LNTH $SRPT Been adding to all these.

0 · Reply

DKFutureInvest Aug. 18 at 9:15 PM

$LNTH Kinda wondering if today was about closing the gap from 11th, just 10 cents above that close was high of day. I guess we see tomorrow if we continue bullish or not.

1 · Reply

DKFutureInvest Aug. 18 at 7:23 PM

$LNTH Really strange price action.

0 · Reply

Jjjsn33dfulthings Aug. 18 at 2:59 PM

$LNTH Well I think the 1500 80 puts from next week are either now the 150 40 dollar Jan calls or the 300 60 dollar dec calls. Prob the 40 since those are like 2k each

0 · Reply

Jjjsn33dfulthings Aug. 18 at 1:36 PM

$LNTH told ya. They love messing with those monthlies. If you are able to roll on the Friday or whatever it almost always pays off. I normally close on that Monday but have kept some of it looks like the trend is changing

0 · Reply

Estimize Aug. 18 at 11:00 AM

Wall St is expecting 1.32 EPS for $LNTH Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/lnth?chart=historical&metric_name=eps&utm_co

0 · Reply

RadioIsotope25 Aug. 18 at 3:50 AM

$RADX Biotech Daily https://mcusercontent.com/2020b74e9b9a298e9cadee03b/files/86b90175-7040-d85a-e568-7d8751aa61b8/RAD_Aug_15_2025.pdf $MNPR $LNTH

0 · Reply

Market Cap	3.96B
Revenue (ttm)	1.53B
Net Income (ttm)	312.44M
EPS (ttm)	N/A
PE Ratio	10.88
Forward PE	11.71
Profit Margin	20.37%
Debt to Equity Ratio	0.49

Volume	2,307,600
Avg Vol	1,661,256
Day's Range	N/A - N/A
Shares Out	67.99M
Stochastic %K	78%
Beta	0.14
Analysts	Strong Sell
Price Target	$95.54